Latest News
Sakar Healthcare Limited
- Sakar Healthcare Q2 profit jumps 149% to ₹11.3 crore as revenue rises 52% to ₹87.4 crore; EBITDA margin at 27.85%
- Sakar Healthcare Reports Q2 Standalone Net Profit of ₹11.3 Crore Versus ₹4.5 Crore YoY
- Here's Why We Think Sakar Healthcare (NSE:SAKAR) Might Deserve Your Attention Today
- Sakar Healthcare Starts Commercial Cancer Drug Supplies
- Sakar Healthcare Begins Commercial Oncology Supplies from EU GMP Site for Global Expansion
- Sakar Healthcare NSE:SAKAR Trading Window Closure October 2026
Headlines from the last 30 days, linking to the original publishers. See all market news →